Now Inhaled Cancer Drug Option...
Pediatric cancer specialists at The Children's Hospital at Montefiore (CHAM) are investigating a new type of inhalation chemotherapy with the potential to treat children with a deadly bone cancer that has spread to their lungs.
In the phase 2 study, children use a nebulizer to inhale cisplatin, a standard cancer drug that has been specially encapsulated in protective fatty protein bubbles. Because it is inhaled rather than administered systemically, the drug can penetrate deep into the lungs and come into direct contact with the metastasized bone cancer cells, known as osteosarcoma cells. Children receive this treatment in a special inhalation tent that contains purified air. CHAM is the only pediatric hospital using cisplatin inhalation therapy for osteosarcoma.
Read full story here.
In the phase 2 study, children use a nebulizer to inhale cisplatin, a standard cancer drug that has been specially encapsulated in protective fatty protein bubbles. Because it is inhaled rather than administered systemically, the drug can penetrate deep into the lungs and come into direct contact with the metastasized bone cancer cells, known as osteosarcoma cells. Children receive this treatment in a special inhalation tent that contains purified air. CHAM is the only pediatric hospital using cisplatin inhalation therapy for osteosarcoma.
Read full story here.
posted by DevilzOwn at 8:18 AM
<< Home